Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Financing

<< Previous

Bullboard Posts

Next >>

Comment by steadfaston Jan 20, 2021 1:03pm

265 Views

Post# 32334378

RE:RE:RE:Financing

Redbaron - The 35 cent wts = $3,850,000
The 30 cent wts = 4,032,049
Total $7,882,049
Do you have a few sentences you can share with the BB from
Chris Temple, The National Investor from his Report of $8 share?
I feel with attaining The Holy Grail of insulin independence his $8 makes sense.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market